New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.

Int J Pharm

Institut Charles Gerhardt Montpellier UMR 5253 CNRS-UM2-ENSCM-UM1, Matériaux Avancés pour Catalyse et Santé, ENSCM, 8 rue de l'Ecole Normale, 34296 Montpellier Cedex 5, France.

Published: January 2012

A hot melt dispersion method was used to prepare new sustained release ibuprofen composite microparticles of a solid lipid at ambient temperature, cetyl alcohol. The dispersion of colloidal silicon dioxide nanoparticles (hydrophilic Aerosil 200 or hydrophobic Aerosil R974) either in the oily phase or in the aqueous phase led to the preparation of large (about 400 μm diameter) surfactant free free-flowing particles. Mapping-scanning electronic microscopy using silicon probe revealed that silicon was in the oily core in all cases. The nature of silica nanoparticles and the way used for their dispersion influenced the internal structure of the composite microparticles and the aggregation of nanoparticles in the core of the microparticles. Hydrophobic Aerosil R974 allowed the formation of homogeneous microparticles. Although silica nanoparticles had no influence on thermic profile, crystalline state of ibuprofen and lipid, they had an influence on the kinetics drug release related to the increase of the size of the composite solid lipid microparticles prepared.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpharm.2011.10.027DOI Listing

Publication Analysis

Top Keywords

solid lipid
12
lipid microparticles
8
composite microparticles
8
hydrophobic aerosil
8
aerosil r974
8
silica nanoparticles
8
microparticles
6
microparticles controlled
4
controlled ibuprofen
4
ibuprofen release
4

Similar Publications

Aim: Abemaciclib (ABE) is an anticancer drug that suffers from low bioavailability and multidrug resistance. This study aims to develop ABE-loaded solid lipid nanoparticles (ABE-SLNs), which will enhance drug solubility and lead to increased cellular uptake and enhanced cytotoxicity when delivering tumor cells.

Methods: Melt emulsification followed by ultrasonication was used as a method of preparation and Quality-by-Design (QbD) was utilized to optimize ABE-SLNs.

View Article and Find Full Text PDF

Preparation and characterization of tildipirosin-loaded solid lipid nanoparticles for the treatment of intracellular infections.

Biomater Sci

January 2025

School of Chemistry, Chemical Engineering and Life Science, Hubei Key Laboratory of Nanomedicine for Neurodegenerative Diseases, Wuhan University of Technology, 122 Luoshi Road, Wuhan 430070, China.

To enhance the antibacterial efficacy of tildipirosin against (S.A.) infections, optimized solid lipid nanoparticles loaded with tildipirosin (SLN-TD) were developed, using docosanoic acid (DA), octadecanoic acid (OA), hexadecanoic acid (HA), and tetradecanoic acid (TA) as lipid components.

View Article and Find Full Text PDF

Reducing butter firmness with chemically esterified butter oil.

JDS Commun

January 2025

Department of Food Science and Technology, The Ohio State University, Columbus, OH 43210.

In a consumer-centric environment, food products are created and focused on the consumer's experience and desires. One important food product used around the world is butter. Consumers expect that when they take their butter out of the refrigerator, it will be able to spread nicely and evenly; however, with conventional butter, which does not include any added vegetable oils, achieving a soft, spreadable butter is rare.

View Article and Find Full Text PDF

Aim: The study aimed to formulate solid lipid nanoparticles (SLNs) for the transdermal delivery of PPL to improve skin retention and efficacy.

Materials And Method: The particle size distribution of SLNs was determined and the morphology of SLNs was also analyzed by SEM. , and evaluations were done for PPL loaded SLN.

View Article and Find Full Text PDF

Gene therapy has long been a cornerstone in the treatment of rare diseases and genetic disorders, offering targeted solutions to conditions once considered untreatable. As the field advances, its transformative potential is now expanding into oncology, where personalized therapies address the genetic and immune-related complexities of cancer. This review highlights innovative therapeutic strategies, including gene replacement, gene silencing, oncolytic virotherapy, CAR-T cell therapy, and CRISPR-Cas9 gene editing, with a focus on their application in both hematologic malignancies and solid tumors.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!